2nd Quarter - Termination

ROCK & ASSOCIATES for VETERINARY PHARMACIES OF AMERICA, INC.

Firm
Client
Income
$7,500
Expenses
—
Terminated
May 31, 2023

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Legislation regulating compounding pharmacies.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Legislation regulating compounding pharmacies.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Legislation regulating compounding pharmacies.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.